Merck & Co. Inc. stock outperforms competitors on strong trading day
Merck & Co. Inc. closed 29.59% below its 52-week high of $134.63, which the company reached on June 25th.
Is Merck & Co Inc. (NYSE:MRK) the Most Profitable Value Stock to Buy Now?
We recently published a list of 10 Most Profitable Value Stocks to Buy Now. In this article, we are going to take a look at where Merck & Co Inc. (NYSE:MRK) stands against other profitable value ...
Merck KGaA: Still A Bit Too Expensive
Merck KGaA's stock remains a 'hold' due to its high valuation, trading at an earnings multiple of around 20 and a 4.5% free ...
Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRK
NEW YORK, NY / ACCESS Newswire / March 17, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn ...
Why Organon Is A Top Pick For Income Investors
Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for ...
Levi & Korsinsky Notifies Shareholders of Merck & Co., Inc. (MRK) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESS Newswire / March 17, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn ...
Fintel on MSN10h
Craig-Hallum Initiates Coverage of Personalis (PSNL) with Buy Recommendation
Fintel reports that on March 17, 2025, Craig-Hallum initiated coverage of Personalis (NasdaqGM:PSNL) with a Buy ...
Fintel on MSN16h
HC Wainwright & Co. Downgrades Sutro Biopharma (STRO)
Fintel reports that on March 17, 2025, HC Wainwright & Co. downgraded their outlook for Sutro Biopharma (NasdaqGM:STRO) from ...
BioPharma Dive18h
Latigo raises $150M to get non-opioid pain drugs through key tests
The round, which included more than a dozen investment firms, should give the startup enough cash to get late-stage data for ...
Merck to close Pennsylvania plant
Pharmaceutical giant Merck will close its plant in Northumberland County, Pennsylvania. According to a WARN Notice filed with ...
Pliant Therapeutics' Investigational Cancer Drug Shows Antitumor Activity Across Multiple Tumor Types
Pliant Therapeutics' PLN-101095 showed partial responses in ICI-refractory tumors, with a 50% ORR at the highest dose tested ...
Big pharma fears best-selling drugs in crosshairs of US-EU tariff spat
LONDON (Reuters) -Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff wars, hoping to avert price spikes on top-selling medicines ...